March 3, 2026Transplantation and Cellular Therapy0 citations
Outcomes of Dual Umbilical Cord Blood Vs Mismatched Unrelated Donor Stem Cell Transplants with Post-Transplant Cyclophosphamide Based Graft-Versus-Host Disease Prophylaxis
Dual umbilical cord blood transplants lead to improved outcomes in graft-versus-host disease management, particularly in immunocompromised patients.
Patients receiving dual umbilical cord blood transplants show a notable reduction in incidence rates of complications from mismatched donor transplants.
Assessment using stem cell transplant records highlights the benefits of dual umbilical cord blood in treating hematologic malignancies rapidly.
Further exploration into dual umbilical cord blood viability is needed to refine transplant protocols and enhance patient outcomes.